M4MM
DEA Opens Hearing on Adult-Use Cannabis Federal Schedule III Status
ARLINGTON – The Drug Enforcement Administration began hearings Monday on a proposal to reclassify Cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA), a proceeding officials and advocates on both sides ...
Helus Pharma Advances Phase 3 Trial for Novel Therapy in MDD
NEW YORK – Helus Pharma, the business name now used by Cybin Inc., announced that enrollment in its APPROACH Phase 3 trial has passed the 86% mark. The trial is testing HLP003, the company's lead ...
Hemp THC Beverages Return to Ohio Shelves
CLEVELAND – Hemp-derived THC drinks are back on a limited number of Ohio shelves after U.S. District Judge Jeffrey Helmick temporarily blocked the state from enforcing its newest hemp licensing law against a group of ...
Delaware Moves to Regulate THC-Infused Beverages
DOVER – Delaware's Senate Banking, Business, Insurance & Technology Committee advanced House Bill 373, sending the measure to the Senate Finance Committee and bringing it a step closer to a full Senate vote. The action ...
AMASS Invests in Hemp-Derived THC Beverage Brand Afterdream
LOS ANGELES – AMASS Brands Group, a California-based multi-category beverage platform, has entered into a Simple Agreement for Future Equity (SAFE) in Afterdream, a hemp-derived THC beverage brand. The agreement grants AMASS the right to ...
Nebraska Takes First Step Toward State-Grown Medical Cannabis Supply
LINCOLN – Nebraska’s medical Cannabis program, approved by voters in 2024, has reached a notable early milestone. State regulators recently authorized the first licensed cultivator to begin planting, marking concrete progress in building a regulated ...
Ora Pharm Completes Helius Acquisition, Becomes New Zealand’s Largest Medical Cannabis Company
AUCKLAND – Ora Pharm has completed the acquisition of the key assets of Helius Therapeutics and restarted manufacturing operations. The agreement covers Helius's EU-GMP-certified production plant, its remaining inventory, and its operating licenses, though it ...
DEA Opens Hearing on Adult-Use Cannabis Federal Schedule III Status
ARLINGTON – The Drug Enforcement Administration began hearings Monday on a proposal to reclassify Cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA), a proceeding officials and advocates on both sides ...
Helus Pharma Advances Phase 3 Trial for Novel Therapy in MDD
NEW YORK – Helus Pharma, the business name now used by Cybin Inc., announced that enrollment in its APPROACH Phase 3 trial has passed the 86% mark. The trial is testing HLP003, the company's lead ...
Hemp THC Beverages Return to Ohio Shelves
CLEVELAND – Hemp-derived THC drinks are back on a limited number of Ohio shelves after U.S. District Judge Jeffrey Helmick temporarily blocked the state from enforcing its newest hemp licensing law against a group of ...
Why the Endocannabinoid System Is the Future of Cannabis Medicine
NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The ...
Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine
NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune ...
Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine
NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of ...
Cresco Labs Reports Q1 2026 Financial Results
CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With ...
Cronos Group Reports Q1 2026 Financial Results
TORONTO – Cronos Group Inc. posted record net revenue and gross profit for the first quarter of 2026, driven by higher sales volumes, a favorable product mix, and gains in key markets. The Cannabis company ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past two weeks brought measurable movement across federal policy, corporate financial reporting, international deals, and product categories in the U.S. Cannabis sector. Operators absorbed details on rescheduling implications, watched hemp-derived THC ...
Congress Presses FDA on Psychedelic Therapy Approvals
WASHINGTON – A bipartisan coalition of 32 House members sent a formal letter to FDA Commissioner Martin A. Makary urging the agency to move faster on ongoing reviews of psychedelic treatments. The letter stated that ...
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, showing modest year-over-year revenue growth from continuing operations and sustained operational performance across its core Northeast markets. The company reported ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent narratives – a retail operation contending with sustained pricing pressure, and a company whose federal tax obligations are, for the ...
LEEF Brands Reports Q1 2026 Financial Results
VANCOUVER – LEEF Brands Inc. reported its strongest financial quarter since inception, showing marked operational progress and turning what had been a loss position a year ago into meaningful profitability, all without adding a single ...
GTI Reports Q1 2026 Financial Results
CHICAGO – Green Thumb Industries Inc. released its first-quarter 2026 financial results, highlighting steady performance in a market still marked by price competition and variable demand. The multistate Cannabis operator posted steady revenue growth, alongside ...
Target Expands Hemp-Derived THC Beverage Sales Area
NEW YORK – Target is broadening its reach in the hemp-derived THC beverage category, adding the products to more than 300 stores across Florida, Texas and parts of Illinois. The mass retailer confirmed the move ...
Cannara Biotech Wraps Up Medican Organic Acquisition
MONTREAL – Cannara Biotech Inc. announced the closing of a transaction to acquire all of the shares of Medican Organic Inc. for an aggregate purchase price of $2.8 million. On the surface, that's a modest ...
Aprio Targets Cannabis Sector in Price Kong Acquisition
ATLANTA-PHOENIX – Aprio, the 20th largest business advisory and accounting firm in the United States, announced it had entered into an agreement to acquire Price Kong, a Phoenix-based CPA and advisory firm. The transaction, effective ...
RYTHM Reports Q1 2026 Financial Results
ROLLING MEADOWS – RHYTHM Inc. disclosed stronger results for the first quarter of 2026 as the company continued its shift toward branded hemp-derived THC products and licensing deals. Revenue from continuing operations came in at ...
